• Home
  • Grass Allergy
  • About GRADUATE
  • Study Location
  • COVID-19 Statement
  • About ITN
  • About RBH Allergy Dept
  • Privacy Policy
  • Policies, Standards & Legislation
  • Understanding Clinical Trials
Skip to main content
Immune Tolerance Network

Developing, funding and conducting clinical trials in immune tolerance

Share This
Home

A clinical trial exploring long-term protection from seasonal hay fever.

 

GRADUATE is no longer recruiting participants.

 

COVID-19 Statement

  • Home
  • Grass Allergy
  • About GRADUATE
  • Study Location

About the Allergy Department at the RBH

Professor Stephen R. Durham
Head of the Section of Allergy & Clinical Immunology

Stephen R. Durham is Head of the Section of Allergy & Clinical Immunology at Imperial College London and the Clinical Lead for allergy services at Royal Brompton and Harefield Hospitals. He is committed to running a high quality NHS Allergy Service and improving the quality of life of allergy sufferers.

He leads a world class research group that performs translational (bench-to-bedside) research focused on developing and improving treatments for hay fever and asthma. He has a special interest in allergen immunotherapy, a treatment that not only treats the symptoms of hay fever but has potential to induce long-term disease remission.

 

Dr. Guy Scadding

Co-Investigator, Clinical Senior Lecturer, and one of the study doctors on the study.

Dr. Mohamed Shamji

Co-Investigator, Reader in Immunology & Allergy, and leads the laboratory team on the study.

Dr. Aarif Eifan

Clinical Research Fellow, and one of the study doctors on the study.

Alexandra Fedina

Senior Clinical Research Nurse on the study.

Martin Penagos

Research Assistant on the study.

Lisa Curry

Clinical Trials Manager for the study
  • About ITN
  • About the Team
  • Privacy Policy
  • Policies, Standards & Legislation
  • Understanding Clinical Trials

GRADUATE is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded) | V1.3 | 2021-03-25 | REC Ref # 20/NW/0089
 

           

NIH National Institute of Allergy and Infectious Diseases